Detalhe da pesquisa
1.
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Lancet Oncol
; 21(1): 145-161, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31786124